Your shopping cart is currently empty

ATN-161 acetate, a pentapeptide compound derived from the synergistic region of fibronectin, is a non-competitive integrin-alpha5 antagonist with antitumor activity that attenuates the pathology of caerulein-induced acute pancreatitis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | In Stock | In Stock | |
| 5 mg | $483 | In Stock | In Stock | |
| 10 mg | $692 | In Stock | In Stock | |
| 25 mg | $1,080 | In Stock | In Stock | |
| 50 mg | $1,490 | In Stock | In Stock | |
| 100 mg | $1,970 | - | In Stock | |
| 200 mg | $2,690 | - | In Stock |
| Description | ATN-161 acetate, a pentapeptide compound derived from the synergistic region of fibronectin, is a non-competitive integrin-alpha5 antagonist with antitumor activity that attenuates the pathology of caerulein-induced acute pancreatitis. |
| In vitro | The treatment regimen of ATN-161 acetate in combination with 5-FU was able to significantly inhibit the proliferation of tumor cells compared to control and monotherapy. In addition, the combination treatment significantly increased the proportion of TUNEL-positive tumor cells, while monotherapy failed to increase TUNEL-positive cells. ATN-161 acetate significantly reduced the number of cancer cells after 48 hours of culture (21% reduction) compared to the control group. [1] ATN-161 acetate prevented vascular endothelial growth factor-induced migration and capillary formation of hCECs, but had no significant effect on proliferation. Starting at 100 nM, ATN-161 acetate decreased the number of cells migrating in response to VEGF in a dose-dependent manner (compared to the VEGF group). [2] |
| In vivo | Injection of ATN-161 acetate after laser photocoagulation reduced choroidal neovascularization (CNV) leakage and neovascularization with an inhibitory effect comparable to that of AF564. [2] |
| Synonyms | ATN-161 acetate(262438-43-7 Free base), ATN161 acetate, Ac-PHSCN-NH2 acetate |
| Molecular Weight | 657.7 |
| Formula | C25H39N9O10S |
| Cas No. | 904763-58-2 |
| Smiles | C(C)(O)=O.C(N[C@@H](CC1=CN=CN1)C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(N)=O)=O)CS)=O)CO)=O)(=O)[C@H]2N(C(C)=O)CCC2 |
| Relative Density. | no data available |
| Sequence | Ac-Pro-His-Ser-Cys-Asn-NH2.CH3CO2H |
| Sequence Short | PHSCN |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.